Medizalbu is a Human Albumin 20% Injection formulated to help restore and maintain plasma volume in patients suffering from hypoalbuminemia, burns, liver disease, shock, trauma, major surgery, and other critical medical conditions. Human albumin is a naturally occurring plasma protein that plays a vital role in maintaining blood volume and transporting essential substances throughout the body.
Medizalbu is manufactured under stringent quality standards to ensure safety, efficacy, and reliability for hospitals, healthcare providers, and distributors.
📞 Contact Number: +91 9876543210
🌐 Website: www.mediziabiotech.com
Human Albumin 20% Injection is a sterile intravenous solution containing purified human serum albumin. It is primarily used as a plasma volume expander and protein replacement therapy in critically ill patients.
Albumin helps maintain colloid osmotic pressure, supports fluid balance, and improves blood circulation. It is widely used in intensive care units (ICUs), emergency medicine, nephrology, hepatology, and surgical care.
Product Name: Medizalbu
Medizalbu is developed to meet international pharmaceutical quality standards and provides healthcare professionals with a dependable albumin solution for critical patient management.
Key features include:
High-quality Human Albumin 20% Solution
Sterile intravenous infusion
Excellent plasma volume expansion
Reliable protein replacement therapy
Hospital-grade formulation
Manufactured under strict GMP-compliant processes
Human Albumin 20% Injection is commonly prescribed for:
Hypoalbuminemia
Liver cirrhosis
Severe burns
Trauma management
Major surgical procedures
Septic shock
Hypovolemia
Plasma exchange procedures
Intensive care treatment
Nephrotic syndrome
Fluid resuscitation
Critical care patients
Helps rapidly increase circulating plasma volume during shock and blood loss.
Replaces lost albumin in patients with severe hypoalbuminemia.
Improves circulation and oxygen delivery to vital organs.
Helps prevent edema while maintaining intravascular fluid volume.
Preferred in ICUs, emergency departments, liver care, nephrology, and surgical units.
Albumin increases oncotic pressure inside blood vessels, drawing fluid from body tissues into the bloodstream. This helps:
Improve circulation
Stabilize blood pressure
Enhance tissue perfusion
Reduce fluid accumulation
Restore plasma protein levels
Medizalbu Human Albumin 20% Injection should be administered only by qualified healthcare professionals through intravenous infusion.
The dosage depends on:
Patient weight
Clinical condition
Albumin level
Fluid status
Physician's assessment
Patients should be monitored throughout the infusion.
Like all medicines, Human Albumin 20% Injection may cause side effects in some patients, including:
Fever
Chills
Nausea
Headache
Skin rash
Allergic reactions
Changes in blood pressure
Fluid overload in susceptible patients
Seek immediate medical attention if severe allergic reactions occur.
Before administering Medizalbu:
Use only under medical supervision.
Monitor cardiovascular status.
Assess fluid balance regularly.
Use cautiously in heart failure patients.
Avoid use in patients with known hypersensitivity to albumin preparations.
Store according to the manufacturer's recommendations.
Protect from excessive heat and direct sunlight.
Do not freeze.
Keep out of reach of children.
Medizalbu is trusted by hospitals and healthcare providers because it offers:
Premium quality Human Albumin 20% Injection
Reliable clinical performance
Strict quality assurance
Safe manufacturing standards
Timely bulk supply
Competitive pricing
Professional customer support
📞 Contact Number: +91 9876543210
🌐 Website: www.mediziabiotech.com
If you are looking for a trusted Human Albumin 20% Injection Manufacturer, Supplier, Exporter, or Third-Party Manufacturing Partner, Medizalbu offers dependable pharmaceutical solutions for hospitals, distributors, wholesalers, and healthcare organizations.
We support:
Bulk Orders
Hospital Supply
Institutional Supply
Government Tenders
Pharmaceutical Distribution
Third-Party Manufacturing
Contract Manufacturing
Export Opportunities
📞 Contact Number: +91 9876543210
🌐 Website: www.mediziabiotech.com
It is used to restore plasma volume and treat conditions such as hypoalbuminemia, shock, burns, liver disease, and critical illness.
Yes. Medizalbu is administered only through intravenous infusion under medical supervision.
Yes. It is commonly used in intensive care units for critically ill patients requiring plasma volume expansion.
When administered according to medical guidelines by healthcare professionals, it is generally considered safe and effective.
Medizalbu Human Albumin 20% Injection is a trusted solution for plasma volume expansion and albumin replacement therapy. It plays a critical role in the management of critically ill patients, including those with liver disease, burns, trauma, hypoalbuminemia, and major surgeries. With high manufacturing standards, dependable quality, and reliable supply capabilities, Medizalbu is an excellent choice for hospitals, distributors, and healthcare providers seeking premium Human Albumin 20% Injection in India.
📞 Contact Number: +91 9876543210
🌐 Website: www.mediziabiotech.com